MAOA knockout mice are more susceptible to seizures but show reduced epileptogenesis

Epilepsy Research

Volumn 59, Issue 1, 2004, Pages 25-34

  Teskey, G Campbell ^a   Radford, Kathleen S ^a   Seif, Isabelle ^b   Dyck, Richard H ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b University of Paris XI   (France)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Amygdala; Amygdala kindling; Cortical reorganization; MAOA; PTZ kindling; Seizure; Serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; NORADRENALIN; PENTETRAZOLE; SEROTONIN;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ELECTRODE; EMBRYO; EMBRYO DEVELOPMENT; EPILEPTOGENESIS; FEMALE; KINDLING; KNOCKOUT MOUSE; LATENT PERIOD; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; SEROTONIN BRAIN LEVEL; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; ELECTRIC STIMULATION; EPILEPSY; FEMALE; KINDLING, NEUROLOGIC; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MONOAMINE OXIDASE; PENTYLENETETRAZOLE; SEIZURES;

EID: 2342485878     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2004.03.001     Document Type: Article

References (51)

1. Altshuler L.L., Cohen L., Szuba M.P., Burt V.K., Gitlin M., Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am. J. Psychiatry. 153:1996;529-606
2. Applegate C.D., Tecott L.H. Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp. Neurol. 154:1998;522-530
3. Brown C.E., Seif I., De Maeyer E., Dyck R.H. Development of the zincergic innervation of somatosensory cortex in postnatal MAO-A knockout mice. Dev. Brain Res. 142:2003;19-29
4. Camu W., Marlier L., Lerner-Natoli M., Rondouin G., Privat A. Transplantation of serotonergic neurons into the 5, 7-DHT-lesioned rat olfactory bulb restores the parameters of kindling. Brain Res. 518:1990;23-30
5. Carre G., Harley C. DSP-4 treatment accelerates kindling. Exp. Neurol. 94:1986;812-816
6. Cases O., Lebrand C., Giros B., Vitalis T., De Maeyer E., Caron M.G., Price D.J., Gaspar P., Seif I. Plasma membrane transporters of serotonin, dopamine and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knockouts. J. Neurosci. 18:1998;6914-6927
7. A. Science. 268:1995;1763-1766
8. Cases O., Vitalis T., Seif I., De Maeyer E., Sotelo C., Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron. 16:1996;297-307
9. Chevassus-au-Louis N., Baraban S.C., Gaïarsa J.-L., Ben-Ari Y. Cortical malformations and epilepsy: new insight from animal models. Epilepsy Res. 40:1999;811-821
10. Corcoran M.E., Mason S.T. Role of forebrain catecholamines in amygdaloid kindling. Brain Res. 190:1980;473-484
11. Czuczwar S.J., Tutka P., Klonowski P., Kleinrok Z. N(G)-nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur. J. Pharmacol. 366:1999;137-142
12. De la Torre J.C., Kawanaga H.M., Mullan S. Seizure susceptibility after manipulation of brain serotonin. Arch. Int. Pharmacodyn. Ther. 188:1970;298-304
13. Dyck R.H., Bogoch I.I., Marks A., Melvin N.R., Teskey G.C. Enhanced epileptogenesis in S100B knockout mice. Mol. Brain Res. 106:2002;22-29
14. Endo K., Morita K., Uchiyama Y., Takada K., Tsujimoto A., Dohi T. Involvement of brain serotonergic function in lidocaine-induced convulsions in mice. Jpn. J. Pharmacol. 62:1993;325-328
15. Evrard A., Malagié I., Laporte A.M., Boni C., Hanoun N., Trillat A.C., Seif I., De Maeyer E., Gardier A., Hamon M., Adrien J. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Euro. J. Neurosci. 15:2002;841-851
16. Ferraro T.N., Golden G.T., Smith G.G., St Jean P., Schork N.J., Mulholland N., Schill J., Buono R.J., Berrettini W.H. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J. Neurosci. 19:1999;6733-6739
17. Gellman R.L., Kallianos J.A., McNamara J.O. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development. J. Pharmacol. Exp. Ther. 241:1987;891-898
18. Goddard G.V., McIntyre D., Leech C. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 3:1969;538-544
19. Hendrick V., Stowe Z.N., Altshuler L.L., Mintz J., Hwang S., Hostetter A., Suri R., Leight K., Fukuchi A. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol. Psychiat. 50:2001;775-782
20. Ikemoto K., Kitahama K., Seif I., Maeda T., DeMaeyer E., Valatx J.L. Monoamine oxidase B (MAOB)-containing structures in MAOA-deficient transgenic mice. Brain Res. 771:1997;121-132
21. Jacobs K.M., Kharazia V.N., Prince D.A. Mechanisms underlying epileptogenesis in cortical malformations. Epilepsy Res. 36:1999;165-188
22. Kilian M., Frey H.H. Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology. 12:1973;681-692
23. Kovacs D.A., Zoll J.G. Seizure inhibition by median raphe nuclei stimulation in rat. Brain Res. 70:1974;165-169
24. Kuzniecky R.I., Barkovich A.J. Malformations of cortical development and epilepsy. Brain Dev. 23:2001;2-11
25. Lajard A.M., Bou C., Monteau R., Hilaire G. Serotonin levels are abnormally elevated in the fetus of the monoamine oxidase-A-deficient transgenic mouse. Neurosci. Lett. 261:1999;41-44
26. Lazarova M., Samanin R. Serotonin mediation of the protective effect of clonidine against pentylenetetrazol-induced seizures in rats. Life Sci. 32:1983;2343-2348
27. Lerner-Natoli M., Rondouin G., Malafosse A., Sandillon F., Privat A., Baldy-Moulinier M. Facilitation of olfactory bulb kindling after specific destruction of serotoninergic terminals in the olfactory bulb of the rat. Neurosci. Lett. 66:1986;299-304
28. Lerner-Natoli M. Serotonin and kindling development. J. Neurosci. 36:1987;139-151
29. McIntyre D.C., Saari M., Pappas B.A. Potentiation of amygdala kindling in adult or infant rats by injections of 6-hydroxydopamine. Exp. Neurol. 63:1979;527-544
30. McIntyre D.C., Giugno L. Effect of clonidine on amygdala kindling in normal and 6-hydroxydopamine-pretreated rats. Exp. Neurol. 99:1988;96-106
31. Munkenbeck K.E., Schwark W.S. Serotonergic mechanisms in amygdaloid-kindled seizures in the rat. Exp. Neurol. 76:1982;246-253
32. Pelletier M.R., Corcoran M.E. Intra-amygdaloid infusions of clonidine retard kindling. Brain Res. 598:1992;51-58
33. Pelletier M.R., Corcoran M.E. Infusions of Alpha-2 noradrenergic agonists and antagonists into the amygdala: effects on kindling. Brain Res. 632:1993;29-35
34. Racine R. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. Clin. Neurophysiol. 32:1972;281-294
35. Racine R., Coscina D.V. Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats. Brain Res. Bull. 4:1979;1-7
36. Rebsam A., Seif I., Gaspar P. Refinement of thalamocortical arbors and emergence of barrel domains in the primary somatosensory cortex: a study of normal and monoamine oxidase a knock-out mice. J. Neurosci. 22:2002;8541-8552
37. Ross M.E. Brain malformations, epilepsy, and infantile spasms. Int. Rev. Neurobiol. 49:2002;333-352
38. Salichon N., Gaspar P., Upton A.L., Picaud S., Hanoun N., Hamon M., De Maeyer E., Murphy D.L., Mossner R., Lesch K.P., Hen R., Seif I. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase A and 5-HT transporter knock-out mice. J. Neurosci. 21:2001;884-896
39. Siegel J., Murphy G.J. Serotonergic inhibition of amygdala-kindled seizures in cats. Brain Res. 174:1979;337-340
40. Stach R., Lazarova M.B., Kacz D. Serotonergic mechanism in seizures kindled from the rabbit amygdala. Naunyn-Schmiedeberg's Arch. Pharmacol. 316:1981;56-58
41. Teskey, G.C., 2001. Using kindling to model the neuroplastic changes associated with learning and memory, neuropsyciatric disorders, and epilepsy. In: Shaw, C.A., McEachern, J.C. (Eds.), Towards a Theory of Neuroplasticity. Taylor and Francis, Psychology Press, Philadelphia, PA, pp. 347-358.
42. Thomsen C., Dalby N.O. Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice. Neuropharmacology. 37:1998;1465-1473
43. Toth M., Tecott L. Transgenic approaches to epilepsy. Adv. Neurol. 79:1999;291-296
44. Upton A.L., Salichon N., Lebrand C., Ravary A., Blakely R., Seif I., Gaspar P. Excess of serotonin (5-HT) alters the segregation of ipsilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development. J. Neurosci. 19:1999;7007-7024
45. Vacher C.M., Fretier P., Creminon C., Seif I., De Maeyer E., Calas A., Hardin-Pouzet H. Monoaminergic control of vasopressin and VIP expression in the mouse suprachiasmatic nucleus. J. Neurosci. Res. 71:2003;791-801
46. Vohora D., Pal S.N., Pillai K.K. Thioperamide, a selective histamine H receptor antagonist, protects against PTA-induced seizures in mice. Life Sci. 66:2000;297-301
47. Wada Y., Hasegawa H., Nakamura M., Yamaguchi N. Suppressive effects of L-5-hydroxytryptophan in a feline model of photosensitive epilepsy. Brain Res. 552:1991;8-12
48. Wada Y., Hasegawa H., Nakamura M., Yamaguchi N. Serotonergic inhibition of the limbic and thalamic seizures in cats. Neuropsychology. 25:1992;87-90
49. Wada Y., Hasegawa H., Nakamura M., Yamaguchi N. Behavioral and electroencephalographic effects of serotonin receptor agonist (5-methoxy-N, N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Neurosci. Lett. 138:1992;115-118
50. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci. Lett. 159:1993;179-182
51. Yuhas Y., Shulman L., Weizman A., Kaminsky E., Vanichkin A., Ashkenazi S. Involvement of tumor necrosis factor alpha and interleukin-1 in enhancement of pentylenetetrazol-induced seizures caused by Shigella dysenteriae. Infect. Immun. 67:1999;1455-1460